190 related articles for article (PubMed ID: 17569611)
1. Role of "handle" region of prorenin prosegment in the non-proteolytic activation of prorenin by binding to membrane anchored (pro)renin receptor.
Nurun NA; Uddin NM; Nakagawa T; Iwata H; Ichihara A; Inagami T; Suzuki F
Front Biosci; 2007 Sep; 12():4810-7. PubMed ID: 17569611
[TBL] [Abstract][Full Text] [Related]
2. Non-proteolytic activation of prorenin: activation by (pro)renin receptor and its inhibition by a prorenin prosegment, "decoy peptide".
Uddin MN; Nabi AH; Nakagawa T; Ichihara A; Inagami T; Suzuki F
Front Biosci; 2008 Jan; 13():745-53. PubMed ID: 17981584
[TBL] [Abstract][Full Text] [Related]
3. 'Decoy peptide' region (RIFLKRMPSI) of prorenin prosegment plays a crucial role in prorenin binding to the (pro)renin receptor.
Nabi AH; Biswas KB; Nakagawa T; Ichihara A; Inagami T; Suzuki F
Int J Mol Med; 2009 Jul; 24(1):83-9. PubMed ID: 19513539
[TBL] [Abstract][Full Text] [Related]
4. Biochemical properties of renin and prorenin binding to the (pro)renin receptor.
Nabi AH; Suzuki F
Hypertens Res; 2010 Feb; 33(2):91-7. PubMed ID: 19942927
[TBL] [Abstract][Full Text] [Related]
5. Prorenin is the endogenous agonist of the (pro)renin receptor. Binding kinetics of renin and prorenin in rat vascular smooth muscle cells overexpressing the human (pro)renin receptor.
Batenburg WW; Krop M; Garrelds IM; de Vries R; de Bruin RJ; Burcklé CA; Müller DN; Bader M; Nguyen G; Danser AH
J Hypertens; 2007 Dec; 25(12):2441-53. PubMed ID: 17984666
[TBL] [Abstract][Full Text] [Related]
6. Prorenin has high affinity multiple binding sites for (pro)renin receptor.
Nabi AH; Biswas KB; Nakagawa T; Ichihara A; Inagami T; Suzuki F
Biochim Biophys Acta; 2009 Dec; 1794(12):1838-47. PubMed ID: 19733264
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of diabetic nephropathy by a decoy peptide corresponding to the "handle" region for nonproteolytic activation of prorenin.
Ichihara A; Hayashi M; Kaneshiro Y; Suzuki F; Nakagawa T; Tada Y; Koura Y; Nishiyama A; Okada H; Uddin MN; Nabi AH; Ishida Y; Inagami T; Saruta T
J Clin Invest; 2004 Oct; 114(8):1128-35. PubMed ID: 15489960
[TBL] [Abstract][Full Text] [Related]
8. Species specificity of prorenin binding to the (pro)renin receptor in vitro.
Biswas KB; Nabi AH; Arai Y; Nakagawa T; Ebihara A; Suzuki F
Front Biosci (Elite Ed); 2010 Jun; 2(4):1234-40. PubMed ID: 20515795
[TBL] [Abstract][Full Text] [Related]
9. Binding properties of rat prorenin and renin to the recombinant rat renin/prorenin receptor prepared by a baculovirus expression system.
Nabi AH; Kageshima A; Uddin MN; Nakagawa T; Park EY; Suzuki F
Int J Mol Med; 2006 Sep; 18(3):483-8. PubMed ID: 16865234
[TBL] [Abstract][Full Text] [Related]
10. Pathologic roles of prorenin and (pro)renin receptor in the eye.
Satofuka S; Ichihara A; Nagai N; Tsubota K; Itoh H; Ishida S
Front Biosci; 2008 May; 13():3884-95. PubMed ID: 18508482
[TBL] [Abstract][Full Text] [Related]
11. Megalin: A Novel Endocytic Receptor for Prorenin and Renin.
Sun Y; Goes Martini A; Janssen MJ; Garrelds IM; Masereeuw R; Lu X; Danser AHJ
Hypertension; 2020 May; 75(5):1242-1250. PubMed ID: 32200675
[TBL] [Abstract][Full Text] [Related]
12. (Pro)renin receptor and prorenin: their plausible sites of interaction.
Nabi AH; Biswas KB; Arai Y; Nakagawa T; Ebihara A; Islam LN; Suzuki F
Front Biosci (Landmark Ed); 2012 Jan; 17(1):389-95. PubMed ID: 22201750
[TBL] [Abstract][Full Text] [Related]
13. Human prorenin structure sheds light on a novel mechanism of its autoinhibition and on its non-proteolytic activation by the (pro)renin receptor.
Morales R; Watier Y; Böcskei Z
J Mol Biol; 2012 Aug; 421(1):100-11. PubMed ID: 22575890
[TBL] [Abstract][Full Text] [Related]
14. Nonproteolytic activation of prorenin contributes to development of cardiac fibrosis in genetic hypertension.
Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M; Suzuki F; Nakagawa T; Nishiyama A; Inagami T; Hayashi M
Hypertension; 2006 May; 47(5):894-900. PubMed ID: 16585419
[TBL] [Abstract][Full Text] [Related]
15. Non-proteolytic activation of human prorenin by anti-prorenin prosegment (pf#1: 1P-15P) antiserum.
Suzuki F; Hatano Y; Nakagawa T; Terazawa K; Gotoh A; Nasir UM; Ishida Y; Nakamura Y
Biosci Biotechnol Biochem; 1999 Mar; 63(3):550-4. PubMed ID: 10227141
[TBL] [Abstract][Full Text] [Related]
16. Molecular analysis of human prorenin prosegment variants in vitro and in vivo.
Mercure C; Thibault G; Lussier-Cacan S; Davignon J; Schiffrin EL; Reudelhuber TL
J Biol Chem; 1995 Jul; 270(27):16355-9. PubMed ID: 7608205
[TBL] [Abstract][Full Text] [Related]
17. Prorenin receptor blockers: effects on cardiovascular complications of diabetes and hypertension.
Ichihara A; Kaneshiro Y; Suzuki F
Expert Opin Investig Drugs; 2006 Oct; 15(10):1137-9. PubMed ID: 16989590
[TBL] [Abstract][Full Text] [Related]
18. The dominant role of the prosegment of prorenin in determining the rate of activation by acid or trypsin: studies with molecular chimeras.
Suzuki F; Nakagawa T; Kakidachi H; Murakami K; Inagami T; Nakamura Y
Biochem Biophys Res Commun; 2000 Jan; 267(2):577-80. PubMed ID: 10631104
[TBL] [Abstract][Full Text] [Related]
19. Human prorenin has "gate and handle" regions for its non-proteolytic activation.
Suzuki F; Hayakawa M; Nakagawa T; Nasir UM; Ebihara A; Iwasawa A; Ishida Y; Nakamura Y; Murakami K
J Biol Chem; 2003 Jun; 278(25):22217-22. PubMed ID: 12684512
[TBL] [Abstract][Full Text] [Related]
20. Contribution of nonproteolytically activated prorenin in glomeruli to hypertensive renal damage.
Ichihara A; Kaneshiro Y; Takemitsu T; Sakoda M; Nakagawa T; Nishiyama A; Kawachi H; Shimizu F; Inagami T
J Am Soc Nephrol; 2006 Sep; 17(9):2495-503. PubMed ID: 16885412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
